MURALI CHINTAGUMPALA to Eye Enucleation
This is a "connection" page, showing publications MURALI CHINTAGUMPALA has written about Eye Enucleation.
Connection Strength
0.336
-
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study. J Clin Oncol. 2019 11 01; 37(31):2883-2891.
Score: 0.167
-
Vitreous Seeds in Retinoblastoma: Clinicopathologic Classification and Correlation. Ophthalmology. 2017 10; 124(10):1540-1547.
Score: 0.036
-
Correlation of Insurance, Race, and Ethnicity with Pathologic Risk in a Controlled Retinoblastoma Cohort: A Children's Oncology Group Study. Ophthalmology. 2016 08; 123(8):1817-1823.
Score: 0.033
-
Residual intraretinal retinoblastoma after chemoreduction failure. Arch Ophthalmol. 2012 Feb; 130(2):246-8.
Score: 0.025
-
Outcomes of integrating genetics in management of patients with retinoblastoma. Arch Ophthalmol. 2011 Nov; 129(11):1428-34.
Score: 0.024
-
Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009 Aug; 133(8):1199-202.
Score: 0.021
-
Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Arch Pathol Lab Med. 2006 Nov; 130(11):1669-72.
Score: 0.017
-
Retinoblastoma: from bench to bedside. Expert Rev Mol Med. 2003 Jan 07; 5(1):1-14.
Score: 0.013